AlzeCure Pharma: Intervju med analytiker Anders Hedlund (video)
Redeye Research Interview
2020/03/24
Redeye tog nyligen upp bevakning på AlzeCure Pharma. I en telefonintervju berättar analytiker Anders Hedlund mer om investeringscaset och bolagets forskningsportfölj.
You need to be a Redeye member to access this content
Become a member to:
Access all our extensive research on 100+ Nordic Tech and Life Science companies
Make smarter investment decisions with the guidance of our experienced analysts
Receive exciting offers to participate in IPO’s and other transactions
By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions